Zoetis ZTS
NYSE ZTS
$75.54 -1.14 (-1.48%)
At close: Aug 20, 2026 · 1:50 PM UTC

Zoetis (ZTS) Gross Margin (2012 - 2026)

Zoetis (ZTS) posted quarterly Gross Margin of 71.66% for Q1 2026, down 22.0% year-over-year from 91.87% in Q1 2025, and up 2.12% quarter-over-quarter from 70.17% in Q4 2025.

Zoetis (ZTS) Gross Margin (2012 - 2026) Analysis & Trends

Zoetis (ZTS) has reported Gross Margin for 15 consecutive years, with 71.66% the latest figure, recorded in Q1 2026.

  • In Q1 2026, Gross Margin fell 22.0% year-over-year to 71.66%; the TTM figure through Mar 2026 stood at 71.76% (up 84.0% YoY), while the FY2025 annual figure was 71.84%, up 121.0% from the prior year.
  • Gross Margin grew to 71.66% in Q1 2026 per ZTS's latest filing, from 70.17% in the prior quarter.
  • Across five years, Gross Margin topped out at 73.62% in Q2 2025 and bottomed at 67.1% in Q4 2023.
  • Historically, Gross Margin has averaged 70.6% across 5 years, with a median of 70.64% in 2024.
  • On a YoY basis, Gross Margin climbed as much as 3714 bps in 2022 and fell as far as 151 bps in 2022.
  • Zoetis' Gross Margin stood at 67.99% in 2022, then retreated by 1 bps to 67.1% in 2023, then climbed by 4 bps to 69.49% in 2024, then climbed by 1 bps to 70.17% in 2025, then gained by 2 bps to 71.66% in 2026.
  • Business Quant data shows ZTS's Gross Margin at 71.66% in Q1 2026, 70.17% in Q4 2025, and 71.54% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Haleon 43.89 Bn 42.93 Bn - -
2 Teva Pharmaceutical Industries 43.01 Bn 39.35 Bn 2.15 Bn 51.98%
3 Zoetis 31.52 Bn 29.84 Bn 1.05 Bn 42.63%
4 Takeda Pharmaceutical 28.61 Bn 22.81 Bn 5.10 Bn 66.66%
5 United Therapeutics 22.17 Bn 19.51 Bn 683.80 Mn 87.30%
6 Viatris 18.73 Bn 17.85 Bn 1.46 Bn 38.77%
7 Neurocrine Biosciences 15.51 Bn 15.12 Bn 935.80 Mn 97.58%
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 58.33%
9 Dr Reddys Laboratories 10.12 Bn 9.96 Bn - -
10 Alkermes 8.12 Bn 7.46 Bn 397.90 Mn 80.22%

Historic Data

Download Data
DateValue
Jun 30, 2026 72.73%
Mar 31, 2026 71.66%
Dec 31, 2025 70.17%
Sep 30, 2025 71.54%
Jun 30, 2025 73.62%
Mar 31, 2025 71.88%
Dec 31, 2024 69.49%
Sep 30, 2024 70.64%
Jun 30, 2024 71.71%
Mar 31, 2024 70.64%
Dec 31, 2023 67.10%
Sep 30, 2023 70.34%
Jun 30, 2023 72.16%
Mar 31, 2023 70.60%
Dec 31, 2022 67.99%
Sep 30, 2022 69.68%
Jun 30, 2022 69.54%
Mar 31, 2022 71.35%
Dec 31, 2021 69.50%
Sep 30, 2021 70.55%